4 Comments
9hEdited

Having worked for 2 of these companies (and I know some folks who have been at all three) it's always interesting to see what it looks like from an outsider perspective.

> The answer is, they never did, unless they were Gingko sockpuppets themselves

But this is just not true.. Do you really think that Ginkgo has literally zero external customers? The link you posted here has 3 or 4 of them and every quarterly earnings report lists more (and not all of them can be disclosed of course).

Ginkgo is also far from the only Bio/agtech making N-fixing bacteria. Pivot bio has done $100s millions in sales off of it.

Expand full comment

ok, I can amend the bit about external customers, I was speaking too loosely.

will also have to see what's going on with pivot bio.

Expand full comment

I invested some money into Scorpius Biologics. So far they turned a lot of my money into very little money. So they do have some technology that makes things disappear apparently.

Expand full comment

Just a terminological point--"synthetic biology" has been used for about 20 years primarily to refer to synthesized life, e.g., Mycoplasma mycoides JCVI-syn1.0. It's also used sometimes to refer to genetically re-engineered organisms, though I think that's needlessly confusing when we already have a distinct term for that. Biological manufacturing is one kind of synthetic biology, but please don't say synthetic biology *is* biomanufacturing.

Expand full comment